DHTKD1 and neoplasm: It contains two genetic modifications: a 24-base pair deletion in E1A, which restricts virus replication in tumor cells, and the addition of the RGD-4C binding motif, which improves the infectivity, allowing the virus to target tumor cells via avβ3 and avβ5 integrins, which are overexpressed in a wide range of tumors.